Aquatic Group Exercise for People With Parkinson Disease

Overview

This study will investigate the impact of land based or aquatic based group exercise on the balance, walking, balance confidence, and quality of life of people with idiopathic Parkinson disease. Participants will be randomized to participate in a land based or aquatic based group exercise program 2 times per week for 12 weeks. Prior to and after participation, balance, walking, quality of life, and balance confidence will be measured by a blinded examiner.

Full Title of Study: “Comparison of Aquatic and Land-based Group Exercise for Individuals With Parkinson Disease”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Single (Outcomes Assessor)
  • Study Primary Completion Date: March 10, 2020

Interventions

  • Other: Land Based Exercise
    • Group exercise intervention will be held 2 times per week for 12 weeks and will include balance training, strengthening, gait training, and cardiovascular training.
  • Other: Aquatic Exercise
    • Group exercise intervention will be held 2 times per week for 12 weeks and will include balance training, strengthening, gait training, and cardiovascular training.

Arms, Groups and Cohorts

  • Experimental: Aquatic Group Exercise
  • Active Comparator: Land Based Group Exercise

Clinical Trial Outcome Measures

Primary Measures

  • Change in Mini-BESTest Score
    • Time Frame: Prior to intervention, after 12 week intervention
    • The Mini-BESTest examines postural control. A higher scores means less balance impairment.
  • Change in Movement Disorder Society-Unified Parkinson Disease Rating Scale (MDS-UPDRS): Part III
    • Time Frame: Prior to intervention, after 12 week intervention
    • The Movement Disorders Society-Unified Parkinson Disease Rating Scale examines motor function for people with Parkinson disease. A higher score indicates higher motor impairment related to Parkinson disease.
  • Change in Gait Speed
    • Time Frame: Prior to intervention, after 12 week intervention
    • The 10 meter walk test will be examined at self selected and fast speeds to examine gait speed.

Secondary Measures

  • Change in Parkinson Disease Questionnaire-39 (PDQ-39)
    • Time Frame: Prior to intervention, after 12 week intervention
    • The Parkinson disease questionnaire-39 measures quality of life for people with Parkinson disease. A higher score means more quality of life limitations related to Parkinson disease.
  • Change in Falls Efficacy Scale-International.
    • Time Frame: Prior to intervention, after 12 week intervention
    • The Falls Efficacy Scale-International measures a person’s balance confidence. A higher score is related to worse balance confidence.

Participating in This Clinical Trial

Inclusion Criteria

  • adults over the age of 18 who have been diagnosed with idiopathic Parkinson disease. – stable dose of levadopa medication for 30 days prior to study initiation – able to walk 20 feet without physical assistance – a referral from a physician to participate in physical therapy Exclusion Criteria:

individuals with:

  • uncontrolled cardiovascular or pulmonary conditions – deep vein thrombosis in the last 6 months – the use of breathing tube or feeding tube – those with an extreme fear of exercising in the water – an active dermatological condition (including eczema, psoriasis, or open wound) -any other neurological condition other than Parkinson disease – a musculoskeletal condition that would impact their ability to participate in the exercise group – cognitive impairment (a score of less than 24/30 on the Mini Mental Status Examination)

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Ithaca College
  • Collaborator
    • Parkinson’s Foundation
  • Provider of Information About this Clinical Study
    • Principal Investigator: Sarah Fishel, Assistant Professor – Ithaca College

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.